China is one of the largest producers of pharmaceutical raw materials (PRMs), largely due to its low production cost advantage and large population. China accounts for roughly 90.0% of global vitamin C output, 70.0% of citric acid output and 90.0% of penicillin output.Rising health concerns among Chinese people and strong global demand led to rapid industry growth in the past five years. Total revenue for the Pharmaceutical Raw Material Manufacturing industry in China is expected to be $79.02 billion in 2017, up 2.7% from 2016. Over the five years, revenue has been increasing steadily at an average annual rate of 7.2%.This industry relies heavily on exports, with over 35% of revenue coming from foreign markets. In 2017, exports are set to reach $28.75 billion, 36.4%...purchase to read more.

Industry Statistics & Market Size
Revenue
$79bn
Annual Growth 12-17
7.2%
Forecast Growth 17-22
Profit
Employment
451,723
Businesses
1,349

Industry Threats & Opportunities

  • China accounts for roughly 80% of global Vitamin C output, 70% of citric acid output, and 90% of penicillin output
  • Industry Report - Starting a New Business Chapter

    As discussed in the Basis of Competition section, companies can be classified into three main strategic groups in the industry, for which levels of barriers to entry are different.CertificationsGood manufacturing procedures (GMP) certification requires companies in the industry to meet certain sanitary standards in all operating aspects, such as raw materials, staff, equipment, manufacturing processes, packaging, transport and quality control. Companies must have GMP certification to operate in the industry, and only products with such certification are permitted to be produced. The State Food and Drug Administration has been gradually raising GMP standards, which has increased entry barriers...purchase to read more.

    Additional Insights for the Pharmaceutical Raw Material Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Pharmaceutical Raw Material Manufacturing Industry are

  • Must have a license
  • Establishment of export markets
  • Development of new products
  • IBISWorld analysts also discuss how external factors such as Policies/Legislation and Household Income in the Pharmaceutical Raw Material Manufacturing industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    What's in this report

    What is the Pharmaceutical Raw Material Manufacturing Industry?

    The Pharmaceutical Raw Material Manufacturing industry in China manufactures active pharmaceutical ingredients for further preparation of finished pharmaceutical products. Typical products in the industry include bacteriophage, endocrine products, basic vitamins, sulfanilamide medicine, salicylate, glucose and alkaloids. This industry acts as a bridge between the upstream chemical industry and the downstream medical market.

    Industry Products
  • Vitamins and minerals
  • Antipyretics and analgesics
  • Antibiotics
  • Preparation adjuncts
  • Others
  • Industry Activities
  • Antibiotic
  • Antipyretic and analgesic
  • Vitamin and mineral
  • Hormone and endocrine function regulator
  • Antineoplastic drug
  • Antiallergic agent
  • Enzyme and other biochemical
  • Antiseptic and disinfectant
  • Preparation adjunct
  • Other chemical raw medicine
  • Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Policies/Legislation
  • Household Income
  • Merchandise Trade - Exports (Total)
  • Age Group (60+)
  • Health Expenditure - Government

  • Current Performance
    Industry profitabilityInternational tradeRegulatory pressures
  • Chart: Revenue Growth

  • Industry Outlook
    ProfitabilityEnterprises and employmentInternational trade
  • Table: Pharmaceutical Raw Material Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Pharmaceutical Raw Material Manufacturing Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Pharmaceutical Manufacturing
  • Pharmacies & Drugstores
  • General Hospitals

  • Key Selling Industries
  • Organic Chemical Material Manufacturing

  • Products & Services
  • Others
  • Vitamins and minerals
  • Antipyretics and analgesics
  • Preparation adjuncts
  • Antibiotics
  • Chart: Pharmaceutical Raw Material Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
  • Direct determinants
  • Indirect determinants

  • Major Markets
  • Exports
  • Preparation manufacturers
  • Hospitals
  • Drug stores
  • Chart: Major Market Segmentation for the Pharmaceutical Raw Material Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Profit
  • Purchases
  • Wages
  • Depreciation
  • Environmental care costs
  • Chart: Cost Structure Benchmarking – Sector vs Pharmaceutical Raw Material Manufacturing

  • Basis of Competition
  • Price
  • Development of new products
  • Production efficiencies

  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the Pharmaceutical Raw Material Manufacturing Industry

  • Industry Globalization
    Shijiazhuang Pharmaceutical Group Co., Ltd., North China Pharmaceutical Corporation, Yifan Pharmaceutical Co. Ltd., Northeast Pharmaceutical Group Co., Ltd., Zhejiang NHU Co., Ltd.,
  • Table: Shijiazhuang Pharmaceutical Group Co., Ltd. - financial performance
  • Table: North China Pharmaceutical Corporation - financial performance
  • Table: Yifan Pharmaceutical Co. Ltd. - financial performance
  • Table: Northeast Pharmaceutical Group Co., Ltd. - financial performance
  • Table: Zhejiang NHU Co., Ltd. - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the Pharmaceutical Raw Material Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the Pharmaceutical Raw Material Manufacturing Industry
    Includes:
  • Industry Revenue (2008-2022)
  • Industry Gross Product (2008-2022)
  • Establishments (2008-2022)
  • Businesses (2008-2022)
  • Employment (2008-2022)
  • Exports (2008-2022)
  • Imports (2008-2022)
  • Wages (2008-2022)
  • Total Assets (2008-2022)
  • Pharmaceutical Raw Materials Output (2008-2022)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Active Pharmaceutical Ingredient
  • The substance in a pharmaceutical drug that is biologically active.
  • Analgesics
  • Drugs that relieve pain without blocking nerve impulse conduction or markedly altering sensory functions.
  • Antipyretics
  • Drugs that reduce body temperature in situations such as fever.
  • What Our Customers Say

    Why buy this report?

    The Pharmaceutical Raw Material Manufacturing market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Pharmaceutical Raw Material Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Pharmaceutical Raw Material Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Pharmaceutical Raw Material Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.

    clear